The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism

The European Respiratory Journal
A SamD Jiménez Castro

Abstract

We compared the test characteristics of the shock index (SI) and the simplified pulmonary embolism severity index (sPESI) for predicting 30-day outcomes in a cohort of 1,206 patients with objectively confirmed pulmonary embolism (PE). The primary outcome of the study was all-cause mortality. The secondary outcome was nonfatal symptomatic recurrent venous thromboembolism (VTE) or nonfatal major bleeding. Overall, 119 (9.9%) out of 1,206 patients died (95% CI 8.2-11.5%) during the first month of follow-up. The sPESI classified fewer patients as low-risk (369 (31%) out of 1,206 patients, 95% CI 28-33%) compared to the SI (1,024 (85%) out of 1,206 patients, 95% CI 83-87%) (p<0.001). Low-risk patients based on the sPESI had a lower 30-day mortality than those based on the SI (1.6% (95% CI 0.3-2.9%) versus 8.3% (95% CI 6.6-10.0%)), while the 30-day rate of nonfatal recurrent VTE or major bleeding was similar (2.2% (95%CI 0.7-3.6%) versus 3.3% (95%CI 2.2-4.4%)). The net reclassification improvement with the sPESI was 13.4% (p = 0.07). The integrated discrimination improvement was estimated as 1.8% (p<0.001). The sPESI quantified the prognosis of patients with PE better than the SI.

Citations

Aug 20, 2011·Chest·Mareike LankeitUNKNOWN Instituto Ramón y Cajal de Investigación Sanitaria Pulmonary Embolism Study Group
Jan 8, 2016·Thrombosis and Haemostasis·David JimenezUNKNOWN PROTECT investigators
May 27, 2011·Thrombosis and Haemostasis·Jacques DonzéDrahomir Aujesky
Nov 10, 2012·Thrombosis and Haemostasis·Wendy ZondagUNKNOWN Hestia Study Investigators
Sep 2, 2015·The American Journal of Emergency Medicine·Karsten KellerWolfgang Dippold
Oct 18, 2015·International Journal of Cardiology·Luca MasottiUNKNOWN TUSCAN-PE Investigators
May 31, 2013·Clinical Cardiology·Sérgio Nuno Craveiro BarraAntónio Leitão Marques
Apr 17, 2016·Journal of Electrocardiology·Karsten KellerWolfgang Dippold
Apr 25, 2016·The American Journal of Emergency Medicine·Karsten KellerWolfgang Dippold
Apr 8, 2015·Advances in Medical Sciences·Karsten KellerJörn Oliver Balzer
Sep 1, 2014·European Heart Journal·Stavros V KonstantinidesUNKNOWN Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)
Apr 26, 2016·International Journal of Cardiology·Leili PourafkariNader D Nader
May 23, 2015·Heart & Lung : the Journal of Critical Care·Harun KundiEnder Ornek
Nov 22, 2012·The American Journal of Cardiology·Luis V PaivaAntónio L Marques
Jul 9, 2016·International Journal of Cardiology·Mihaela CordeanuDominique Stephan
Oct 3, 2014·Singapore Medical Journal·Caio Simoes SouzaMarcelo Palmeira Rodrigues
Sep 12, 2013·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Chunran Tong, Zhonghe Zhang
Sep 12, 2018·European Heart Journal. Acute Cardiovascular Care·Yugo YamashitaTakeshi Kimura
Aug 30, 2018·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Carlos Andrés QuezadaDavid Jimenez
Mar 2, 2016·The European Respiratory Journal·David Jiménez, Roger D Yusen
Nov 2, 2016·The European Respiratory Journal·Deisy BarriosUNKNOWN RIETE investigators
Sep 3, 2011·Journal of Thrombosis and Haemostasis : JTH·D SánchezD Jiménez
Jan 14, 2021·The Journal of Infection·Alberto García-OrtegaMiguel Ángel Martínez-García
Apr 13, 2021·Postgraduate Medicine·William B Stubblefield, Jeffrey A Kline

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.